がん治療の世界市場レポート 2025年

がん治療の市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）10.2%で3,108億5,000万米ドルに成長します。予測期間中に予測される成長は、個別化がん治療に対する需要の増加、外来がん治療への注力の強化、免疫療法の採用率の上昇、新興国におけるヘルスケアアクセスの改善、生活習慣病関連がんの罹患率の増加によってもたらされます。この期間の主要動向には、がん診断の技術的発展、標的ドラッグデリバリーの革新、生物製剤の研究開発投資の増加、AIベースの治療計画の開発、低侵襲がん手術の革新などがあります。

がんの有病率の上昇は、がん治療市場の今後の成長を促進すると予想されます。がんは、体内の異常細胞の制御不能な増殖と拡散を特徴とする疾患群です。がん患者の増加は主に、公害やタバコの煙などの環境発がん性物質にさらされる機会が増えたことに起因しています。がん治療は、既存の症例を治療し、生存率を高め、病気の進行を遅らせることによって、この有病率の上昇を管理するために不可欠です。例えば、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、世界のがん罹患数が2050年までに新たに3,500万人を超え、2022年に報告された推定2,000万人から77％増加すると予測しました。このように、がん罹患率の増加ががん治療市場の拡大に拍車をかけています。

がん治療市場の主要企業は、がん細胞を識別し破壊するために身体の免疫システムを活用することで治療効果を高める免疫腫瘍薬などの革新的治療法の開発に注力しています。免疫オンコロジー治療は、がん細胞をより効果的に標的にして攻撃する免疫系の能力を刺激または増強するがん治療のクラス別です。例えば、2024年12月、インドを拠点とする製薬会社Dr. Reddy's Laboratories Ltd.は、インドで上咽頭がんの治療として承認された最初で唯一の免疫腫瘍薬であるトリパリマブを発売しました。この採用は、この希少で侵攻性の高いがん患者に新たな標的治療の選択肢を提供するもので、免疫系の先進的活性化により予後を改善する可能性があります。インドにおけるToripalimabの発売は、十分な治療を受けていない地域における先進的ながん治療へのアクセスを向上させるというReddy博士の献身的な取り組みを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のがん治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のがん治療市場：成長率分析
• 世界のがん治療市場の実績：規模と成長、2019～2024年
• 世界のがん治療市場の予測：規模と成長、2024～2029年、2034年
• 世界のがん治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のがん治療市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 化学療法
• 標的療法
• 免疫療法
• 放射線療法
• その他の治療タイプ
• 世界のがん治療市場：がんタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液がん
• 乳がん
• 前立腺がん
• 消化器がん
• 婦人科がん
• 呼吸器がんまたは肺がん
• その他のがんタイプ
• 世界のがん治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 専門クリニック
• がん・放射線治療センター
• 世界のがん治療市場、化学療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アルキル化剤
• 代謝拮抗剤
• 抗腫瘍抗生物質
• トポイソメラーゼ阻害剤
• 有糸分裂阻害剤
• コルチコステロイド
• その他の化学療法薬
• 世界のがん治療市場、標的療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• モノクローナル抗体
• チロシンキナーゼ阻害剤（TKI）
• mTOR阻害剤
• プロテアソーム阻害剤
• PARP阻害剤
• その他の標的エージェント
• 世界のがん治療市場、免疫療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 免疫チェックポイント阻害剤
• CAR-T細胞療法
• がんワクチン
• サイトカイン
• 腫瘍溶解性ウイルス療法
• その他の免疫療法
• 世界のがん治療市場、放射線治療のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 外部放射線治療（EBRT）
• 内部放射線療法（密封小線源療法）
• 全身放射線療法
• 定位放射線手術（SRS）
• 強度変調放射線治療（IMRT）
• 画像誘導放射線治療（IGRT）
• 世界のがん治療市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ホルモン療法
• 幹細胞移植
• 光線力学療法
• 凍結療法
• 温熱療法

第7章 地域別・国別分析

• 世界のがん治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のがん治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん治療市場：競合情勢
• がん治療市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline PLC
• Elekta AB
• Exelixis Inc.
• Accuray Incorporated
• Akeso Inc.
• NanobIoTix S.A.
• SOTIO BIoTech a.s.
• AdvanCell Isotopes Pty Ltd
• Axcynsis Therapeutics Pte Ltd
• Clarity Pharmaceuticals Ltd
• Affimed N.V.
• Aptadel Therapeutics S.L.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• がん治療市場、2029年：新たな機会を提供する国
• がん治療市場、2029年：新たな機会を提供するセグメント
• がん治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Cancer therapy refers to treatments aimed at eliminating or controlling cancer cells within the body. It encompasses several methods, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The selection of treatment depends on the cancer's type, stage, location, and the patient's overall health.

The primary types of cancer therapy include chemotherapy, targeted therapy, immunotherapy, radiotherapy, and others. Chemotherapy involves using potent drugs to kill or inhibit the growth of rapidly dividing cancer cells. It is applied to various cancers such as blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory or lung cancer, and more. This treatment is utilized by various end users, including hospitals, specialty clinics, and cancer and radiation therapy centers.

The cancer therapy market research report is one of a series of new reports from The Business Research Company that provides cancer therapy market statistics, including the cancer therapy industry global market size, regional shares, competitors with the cancer therapy market share, detailed cancer therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer therapy industry. This cancer therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cancer therapy market size has grown rapidly in recent years. It will grow from $190.44 billion in 2024 to $210.44 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth during the historic period can be attributed to the rising global prevalence of cancer, increasing adoption of chemotherapy treatments, heightened awareness of early cancer diagnosis, greater availability of oncology specialists, and expanded access to hospital-based treatment services.

The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $310.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth projected for the forecast period is driven by increasing demand for personalized cancer therapies, a stronger focus on outpatient cancer care, rising adoption of immunotherapy, improved healthcare access in emerging economies, and a growing incidence of lifestyle-related cancers. Key trends during this period include technological advancements in cancer diagnostics, innovations in targeted drug delivery, increased investment in biologics research and development, the development of AI-based treatment planning, and innovations in minimally invasive cancer surgeries.

The rising prevalence of cancer is expected to drive growth in the cancer therapy market moving forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increase in cancer cases is mainly due to greater exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy is vital in managing this rising prevalence by treating existing cases, enhancing survival rates, and slowing disease progression. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that global cancer incidence will exceed 35 million new cases by 2050, marking a 77% rise from the estimated 20 million cases reported in 2022. Thus, the growing prevalence of cancer is fueling the expansion of the cancer therapy market.

Leading companies in the cancer therapy market are concentrating on developing innovative treatments, such as immuno-oncology drugs, which enhance treatment effectiveness by leveraging the body's immune system to identify and destroy cancer cells. Immuno-oncology drugs represent a class of cancer therapies that stimulate or boost the immune system's ability to more effectively target and attack cancer cells. For example, in December 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical firm, launched Toripalimab, the first and only immuno-oncology drug approved for treating nasopharyngeal cancer in India. This introduction offers a new, targeted treatment option for patients with this rare and aggressive cancer, potentially improving outcomes through advanced immune system activation. The availability of Toripalimab in India highlights Dr. Reddy's dedication to increasing access to advanced cancer therapies in underserved regions.

In December 2023, Pfizer Inc., a pharmaceutical company based in the US, acquired Seagen Inc. for $43 billion. Through this acquisition, Pfizer seeks to enhance its oncology portfolio by incorporating Seagen's advanced antibody-drug conjugate (ADC) technology to deliver more targeted cancer treatments. Seagen Inc., also based in the US, specializes in developing ADCs that accurately target cancer cells while reducing damage to healthy tissue.

Major players in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., and Aptadel Therapeutics S.L.

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer therapy market includes revenues earned by entities by providing services such as hormone therapy, stem cell transplant, cryoablation, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Chemotherapy; Target Therapy; Immunotherapy; Radiotherapy; Other Therapy Types
• 2) By Cancer Type: Blood Cancer; Breast Cancer; Prostate Cancer; Gastrointestinal Cancer; Gynaecologic Cancer; Respiratory Or Lung Cancer; Other Cancer Types
• 3) By End User: Hospitals; Specialty Clinics; Cancer And Radiation Therapy Centers
• Subsegment:
• 1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Corticosteroids; Other Chemotherapy Drugs
• 2) By Targeted Therapy: Monoclonal Antibodies; Tyrosine Kinase Inhibitors (TKIs); mTOR Inhibitors; Proteasome Inhibitors; PARP Inhibitors; Other Targeted Agents
• 3) By Immunotherapy: Immune Checkpoint Inhibitors; CAR T-cell Therapy; Cancer Vaccines; Cytokines; Oncolytic Virus Therapy; Other Immunotherapies
• 4) By Radiotherapy: External Beam Radiation Therapy (EBRT); Internal Radiation Therapy (Brachytherapy); Systemic Radiation Therapy; Stereotactic Radiosurgery (SRS); Intensity-Modulated Radiation Therapy (IMRT); Image-Guided Radiation Therapy (IGRT)
• 5) By Other Therapy Types: Hormone Therapy; Stem Cell Transplant; Photodynamic Therapy; Cryoablation; Hyperthermia Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Bayer Aktiengesellschaft
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Therapy Market Characteristics

3. Cancer Therapy Market Trends And Strategies

4. Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cancer Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cancer Therapy Market Growth Rate Analysis
• 5.4. Global Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cancer Therapy Total Addressable Market (TAM)

6. Cancer Therapy Market Segmentation

• 6.1. Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Target Therapy
• Immunotherapy
• Radiotherapy
• Other Therapy Types
• 6.2. Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Cancer
• Breast Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Gynaecologic Cancer
• Respiratory Or Lung Cancer
• Other Cancer Types
• 6.3. Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Cancer And Radiation Therapy Centers
• 6.4. Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Mitotic Inhibitors
• Corticosteroids
• Other Chemotherapy Drugs
• 6.5. Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Tyrosine Kinase Inhibitors (TKIs)
• mTOR Inhibitors
• Proteasome Inhibitors
• PARP Inhibitors
• Other Targeted Agents
• 6.6. Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune Checkpoint Inhibitors
• CAR T-cell Therapy
• Cancer Vaccines
• Cytokines
• Oncolytic Virus Therapy
• Other Immunotherapies
• 6.7. Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy (EBRT)
• Internal Radiation Therapy (Brachytherapy)
• Systemic Radiation Therapy
• Stereotactic Radiosurgery (SRS)
• Intensity-Modulated Radiation Therapy (IMRT)
• Image-Guided Radiation Therapy (IGRT)
• 6.8. Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Therapy
• Stem Cell Transplant
• Photodynamic Therapy
• Cryoablation
• Hyperthermia Therapy

7. Cancer Therapy Market Regional And Country Analysis

• 7.1. Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Therapy Market

• 8.1. Asia-Pacific Cancer Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Therapy Market

• 9.1. China Cancer Therapy Market Overview
• 9.2. China Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Therapy Market

• 10.1. India Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Therapy Market

• 11.1. Japan Cancer Therapy Market Overview
• 11.2. Japan Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Therapy Market

• 12.1. Australia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Therapy Market

• 13.1. Indonesia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Therapy Market

• 14.1. South Korea Cancer Therapy Market Overview
• 14.2. South Korea Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Therapy Market

• 15.1. Western Europe Cancer Therapy Market Overview
• 15.2. Western Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Therapy Market

• 16.1. UK Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Therapy Market

• 17.1. Germany Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Therapy Market

• 18.1. France Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Therapy Market

• 19.1. Italy Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Therapy Market

• 20.1. Spain Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Therapy Market

• 21.1. Eastern Europe Cancer Therapy Market Overview
• 21.2. Eastern Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Therapy Market

• 22.1. Russia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Therapy Market

• 23.1. North America Cancer Therapy Market Overview
• 23.2. North America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Therapy Market

• 24.1. USA Cancer Therapy Market Overview
• 24.2. USA Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Therapy Market

• 25.1. Canada Cancer Therapy Market Overview
• 25.2. Canada Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Therapy Market

• 26.1. South America Cancer Therapy Market Overview
• 26.2. South America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Therapy Market

• 27.1. Brazil Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Therapy Market

• 28.1. Middle East Cancer Therapy Market Overview
• 28.2. Middle East Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Therapy Market

• 29.1. Africa Cancer Therapy Market Overview
• 29.2. Africa Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Therapy Market Competitive Landscape And Company Profiles

• 30.1. Cancer Therapy Market Competitive Landscape
• 30.2. Cancer Therapy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Therapy Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca PLC
• 31.3. Novartis International AG
• 31.4. GlaxoSmithKline PLC
• 31.5. Elekta AB
• 31.6. Exelixis Inc.
• 31.7. Accuray Incorporated
• 31.8. Akeso Inc.
• 31.9. Nanobiotix S.A.
• 31.10. SOTIO Biotech a.s.
• 31.11. AdvanCell Isotopes Pty Ltd
• 31.12. Axcynsis Therapeutics Pte Ltd
• 31.13. Clarity Pharmaceuticals Ltd
• 31.14. Affimed N.V.
• 31.15. Aptadel Therapeutics S.L.

32. Global Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Therapy Market

34. Recent Developments In The Cancer Therapy Market

35. Cancer Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cancer Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer